Novartis Pharmaceuticals
Prednisolone(Novartis Pharmaceuticals)은 Solid Tumor 표적 ADC로, Healthy 영역에서 개발·상용화 중입니다. 작용기전: target genes of antipsychotic drugs are mainly enriched in cellular response to dopamine, phospholipase C-activating G protein-coupled receptor signaling pathway. FDA 승인 또는 승인 단계 프로그램입니다. 대표 임상 효능: ORR 47% (ClinicalTrials.gov NCT03172325). 차별점: novel therapeutic targets and corresponding inhibitors is urgently required.
Solid Tumor
Healthy
Recruiting
novel therapeutic targets and corresponding inhibitors is urgently required
target genes of antipsychotic drugs are mainly enriched in cellular response to dopamine, phospholipase C-activating G protein-coupled receptor signaling pathway
Biomarker in Acute Bell's Palsy: A Prospective Cohort Study
차트 로드 중…
임상시험이 많습니다. 임상시험 탭에서 Phase/Status 필터·검색을 사용하세요.
수집된 임상 필드(phase, status, endpoint 등) 기반 자동 요약입니다.
Novartis Pharmaceuticals
Prednisolone(Novartis Pharmaceuticals)은 Solid Tumor 표적 ADC로, Healthy 영역에서 개발·상용화 중입니다. 작용기전: target genes of antipsychotic drugs are mainly enriched in cellular response to dopamine, phospholipase C-activating G protein-coupled receptor signaling pathway. FDA 승인 또는 승인 단계 프로그램입니다. 대표 임상 효능: ORR 47% (ClinicalTrials.gov NCT03172325). 차별점: novel therapeutic targets and corresponding inhibitors is urgently required.
Solid Tumor
Healthy
Recruiting
novel therapeutic targets and corresponding inhibitors is urgently required
target genes of antipsychotic drugs are mainly enriched in cellular response to dopamine, phospholipase C-activating G protein-coupled receptor signaling pathway
Biomarker in Acute Bell's Palsy: A Prospective Cohort Study
차트 로드 중…
임상시험이 많습니다. 임상시험 탭에서 Phase/Status 필터·검색을 사용하세요.
수집된 임상 필드(phase, status, endpoint 등) 기반 자동 요약입니다.